Overview of Dr. Saxena
Dr. Ashish Saxena is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 11 years. He is one of 377 doctors at New York-Presbyterian Hospital and one of 118 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He has more than 30 publications and over 500 citings.
Office
520 East 70th Street
Starr Pavilion, 3rd Floor
New York, NY 10021
Education & Training
- Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, 2013 - 2015
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2010 - 2013
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2007 - 2010
- Stony Brook University Health Sciences Center School of MedicineClass of 2006
- Stony Brook University Graduate SchoolPhD, Genetics, 1999 - 2004
Certifications & Licensure
- NY State Medical License 2010 - 2025
Awards, Honors, & Recognition
- Outstanding House Officer in Ambulatory Care Medicine Albert Einstein College of Medicine/Montefiore Medical Center Department of Medicine, 2010
Publications & Presentations
PubMed
- Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Nonsmall Cell Lung Cancer.Daniel M Libby, Laura J Libby, Xiaoyue Ma, Jason Chua, Tahj Blow
Clinical Lung Cancer. 2024-11-14 - 1 citationsIschemic Stroke with Comorbid Cancer Has Specific miRNA-mRNA Networks in Blood That Vary by Ischemic Stroke Mechanism.Bodie Knepp, Babak B Navi, Fernando Rodriguez, Lisa M DeAngelis, Mitchell S V Elkind
Annals of Neurology. 2024-09-01 - Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study.Anne R Bass, Fenglong Xie, Deanna Jannat-Khah, Nilasha Ghosh, Karmela K Chan
Rheumatology. 2024-06-18
Journal Articles
- Extracellular Vesicles in DLBCL Provide Abundant Clues to Aberrant Transcriptional Programming and Genomic AlterationsSarah C Rutherford, Ashish Saxena, Rita Shaknovich, Blood
Press Mentions
- Minimizing Hair Loss During Chemotherapy: Is It Possible?July 15th, 2019
- The Side Effects of Chemotherapy: Here’s What to ExpectJuly 15th, 2019
- What Is “Chemo Brain” + How Long Does It Last?July 15th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: